Intellectual Property

Katie is a patent litigation specialist with a wealth of experience across the life sciences, telecoms and technology sectors. Katie is well-versed in dealing with major cross-border matters requiring significant coordination across multiple forums, and with a degree in chemistry and biology she is well-placed to advise on highly technical subject matters.

Katie has worked on the litigation of patents across a broad spectrum of technological subject matters, including those relating to antibody and other protein biologics, biosimilars, biological product development and screening platforms, medical devices, medical diagnostics and sequencing technologies, 2G, 3G, 4G and 5G telecommunications, connected cars, consumer products and FRAND/SEP licensing.

2023 to present Linklaters LLP; 2018 to 2023 Kirkland & Ellis International LLP; 2016-2018 self-employed Legal Consultant; 2009-2015 Allen & Overy LLP

The Law Society of England & Wales; International Association for the Protection of Intellectual Property (AIPPI); Pharmaceutical Trade Marks Group (PTMG); ChIPs Network; IPSoc

University of Oxford (Postgraduate Diploma in Intellectual Property Law and Practice, 2012); College of Law, London (Bachelor of Laws; Legal Practice Course, 2008); College of Law, London (Post-Graduate Diploma in Law, 2007); Durham University (B.Sc., Biology and Chemistry, 2006).